These data (originated from TCGA’s genomic profiling of MM [18] and available at [19]) pointed to modest expression levels of uPARAP in most cancers, but high mRNA levels were found in a limited number of cancer types (Figure 1). This evidence concerns the gene MRC2 and Miyoshi myopathy.